Fig. 4From: Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophoresPerformances of the combination of structure-based and ligand-based approach for each NRLiSt BDB dataset. The amount of ligands retrieved during the virtual screening procedure using the combination of structure-based and ligand-based selective pharmacophores is shown in red whereas the number of ligands not covered by the pharmacophores is depicted and labelled in blue Back to article page